JAHA:晚发型肺动脉高压在TGA术后病人中的预后研究

2017-10-26 MedSci MedSci原创

目前,对于大动脉转位(TGA)术后患者的晚发肺动脉高压(PH)的数据尚缺乏。本研究纳入了140名大动脉转位行心房扭转术后的成年患者,平均年龄为37.3±7.8岁,女性占37.1%,以评估TGA术后晚发PH的发病率和临床特点。患者平均随访时间为术后32.3年,在33例有侵入性血液动力学检查的患者中,有18例(54.5%)患者出现PH,诊断为PH的年龄平均为33.9±8.1岁。所有患者的肺动脉压均为毛

目前,对于大动脉转位(TGA)术后患者的晚发肺动脉高压(PH)的数据尚缺乏。

本研究纳入了140名大动脉转位行心房扭转术后的成年患者,平均年龄为37.3±7.8岁,女性占37.1%,以评估TGA术后晚发PH的发病率和临床特点。患者平均随访时间为术后32.3年,在33例有侵入性血液动力学检查的患者中,有18例(54.5%)患者出现PH,诊断为PH的年龄平均为33.9±8.1岁。所有患者的肺动脉压均为毛细血管后动脉压,平均PH为36±12 mm Hg,平均肺毛细血管楔压为28±8 mm Hg,在17例由于心衰而心脏插管的患者中,13例(76.5%)有PH。多元分析后,系统性高血压(OR:9.4, 95% Cl 2.2‐39.4, P=0.002)和心衰(OR:49.8, 95% Cl 8.6‐289.0, P<0.001)是PH发生的独立危险因素,伴有PH的患者更易发生房/室性心律失常,心衰的住院率也更高,行三尖瓣手术的概率也更高,死亡率也更高。

研究结果显示,大动脉转位术后的患者出现晚发型肺动脉高压的概率较高,且这种病人预后更差。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1925191, encodeId=314e19251917e, content=<a href='/topic/show?id=26d633354c9' target=_blank style='color:#2F92EE;'>#动脉高压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33354, encryptionId=26d633354c9, topicName=动脉高压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Jan 05 00:22:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267575, encodeId=8983126e57590, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Oct 28 08:22:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256196, encodeId=1a0a2561968c, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Oct 26 20:43:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256182, encodeId=ddee256182c6, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:43:59 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1925191, encodeId=314e19251917e, content=<a href='/topic/show?id=26d633354c9' target=_blank style='color:#2F92EE;'>#动脉高压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33354, encryptionId=26d633354c9, topicName=动脉高压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Jan 05 00:22:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267575, encodeId=8983126e57590, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Oct 28 08:22:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256196, encodeId=1a0a2561968c, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Oct 26 20:43:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256182, encodeId=ddee256182c6, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:43:59 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
    2017-10-28 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=1925191, encodeId=314e19251917e, content=<a href='/topic/show?id=26d633354c9' target=_blank style='color:#2F92EE;'>#动脉高压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33354, encryptionId=26d633354c9, topicName=动脉高压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Jan 05 00:22:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267575, encodeId=8983126e57590, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Oct 28 08:22:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256196, encodeId=1a0a2561968c, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Oct 26 20:43:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256182, encodeId=ddee256182c6, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:43:59 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
    2017-10-26 三生有幸9135

    学习一下谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1925191, encodeId=314e19251917e, content=<a href='/topic/show?id=26d633354c9' target=_blank style='color:#2F92EE;'>#动脉高压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33354, encryptionId=26d633354c9, topicName=动脉高压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44a360, createdName=jklm09, createdTime=Fri Jan 05 00:22:00 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267575, encodeId=8983126e57590, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Oct 28 08:22:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256196, encodeId=1a0a2561968c, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Thu Oct 26 20:43:00 CST 2017, time=2017-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=256182, encodeId=ddee256182c6, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Oct 26 19:43:59 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
    2017-10-26 131****1460

    学习了受益匪浅

    0

相关资讯

JACC:PCI术后伴复杂病变解剖结构患者的预后研究

接受长期的双联抗血小板治疗的冠脉支架植入伴复杂病变解剖患者的风险和利益尚未阐明。本研究的目的旨在比较和评估冠脉介入治疗(PCI)后接受30个月和12个月双联抗血小板治疗(DAPT)伴或不伴复杂病变解剖效果的研究。本研究对25416名登记的患者和11554名随机的研究对象的心梗、支架血栓和中到重度出血事件的发现风险进行分析评估。复杂的病变解剖包括以下:无保护左主干病变,> 2 病变/血管,长度

JACC:任何可检测的超敏肌钙蛋白水平都与胸痛患者不良预后相关

目前,对于超敏肌钙蛋白(hs-cTn)水平和胸痛但不伴有心梗患者结局的临床研究鲜有报道。本研究提出一个假设:任何可检测到的高水平hs-cTn均与患者的不良结局预后有关。本研究纳入了2011年至2014年22589名胸痛且大于25岁并检测了hs-cTn水平的患者,将出现有可能影响hs-cTn水平的急性情况患者、心梗患者或缺乏能保证hs-cTn水平稳定信息的患者被排除在外,主要观察的事件为全因死亡率、

Free Radic Biol Med:研究揭示多酚类化合物具有保护心血管作用的原因

相关大群体人口研究显示,摄入含多酚类化合物(如黄酮类)的水果和蔬菜对心血管健康具有益处。

JACC:高效抗逆转录病毒疗法对HIV患儿心脏的保护作用研究

在高效抗逆转录病毒疗法(HAART)问世前,心源性死亡和心血管疾病在HIV患儿中是普遍的。本研究的目的旨在评估HAART对HIV患儿远期心血管保护的有效性。本研究(CHAART-2)比较评估了74名接受HAART的HIV患儿的148个超声心动图与140名没有接受HAART但有HIV患儿的860个超声心动图,并通过广义估计方程评价HAART暴露与超声心动图测量之间的关联。分析结果发现,相比于没有接受

JACC:TCS设备在心脏移植患儿中的运用

体外膜式氧合(ECMO)是儿童短期机械循环支持的标准治疗手段,然而,新一代的临时循环支持(TCS)设备相比于ECMO对儿童循环支持的有效性如何尚属未知。本研究目的旨在比较评估TCS较于ECMO对桥接心脏移植存活患儿的有效性是否更佳。本研究纳入了2011年至2015年所有接受心脏移植且接受TCS或ECMO设备循环支持的小于21岁的患儿。接受TCS设备循环支持的患儿与倾向评分配对的接受ECMO设备循环

JACC:肌联蛋白截断的扩张型心肌病的预后研究

目前,对由肌联蛋白截断(TTNtv)所致的扩张型心肌病(DCM)的心脏表型和预后的理解尚未阐明。本次前瞻性观察性队列研究对DCM患者进行了临床评估、心脏磁共振增加检查和TTN测序,并双盲随访,主要终点复合事件是心源性死亡、心律失常和心衰。最终,本研究共纳入716名DCM患者(平均年龄为53.5 ± 14.3岁,男性占65.5%,80.6%患者的纽约心功能评级为I/II),83 (11.6%)名患者